Immune tolerance split between hepatitis B virus precore and core proteins. - Wikidata - awgldk - TriplyDB

Immune tolerance split between hepatitis B virus precore and core proteins.

Immune tolerance split between hepatitis B virus precore and core proteins.

http://www.wikidata.org/entity/Q33835018

about

Precore/core region mutations of hepatitis B virus related to clinical severity Adaptive immunity in the liver The Role of Immune Cells in Chronic HBV Infection Hepatitis B precore protein: pathogenic potential and therapeutic promise Complement and its role in protection and pathogenesis of flavivirus infections Antigenic Switching of Hepatitis B Virus by Alternative Dimerization of the Capsid Protein The clinical implications of hepatitis B virus genotypes and HBeAg in pediatrics Is mother-to-infant transmission the most important factor for persistent HBV infection?The hepatitis B virus ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus ribonuclease H and integrase enzymes Hepatitis B virus molecular biology and pathogenesis Current views and advances on Paediatric Virology: An update for paediatric trainees.Hepatitis B virus and its sexually transmitted infection - an update.Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function.Hepatitis B virus core antigen determines viral persistence in a C57BL/6 mouse model.Phage display creates innovative applications to combat hepatitis B virus Mathematical models of e-antigen mediated immune tolerance and activation following prenatal HBV infection.Th1 and Th2 immune response in chronic hepatitis B patients during a long-term treatment with adefovir dipivoxil.HBsAg as an important predictor of HBeAg seroconversion following antiviral treatment for HBeAg-positive chronic hepatitis B patients Role of the propeptide in controlling conformation and assembly state of hepatitis B virus e-antigen In vivo activation of toll-like receptor-9 induces an age-dependent abortive lytic cycle reactivation of murine gammaherpesvirus-68.Evaluation of changes of serum hepatitis B surface antigen from a different perspective.New point mutations in surface and core genes of hepatitis B virus associated with acute on chronic liver failure identified by complete genomic sequencing.Long-term prognosis of chronic hepatitis B virus infection in the childhood.Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients Chemoimmunotherapy of chronic hepatitis B virus infection in the woodchuck model overcomes immunologic tolerance and restores T-cell responses to pre-S and S regions of the viral envelope protein.Altered Immune Profiles of Natural Killer Cells in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis.Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections.New developments in the treatment of chronic hepatitis B.Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B.Efficacy of lamivudine or entecavir against virological rebound after achieving HBV DNA negativity in chronic hepatitis B patients Clearing Persistent Extracellular Antigen of Hepatitis B Virus: An Immunomodulatory Strategy To Reverse Tolerance for an Effective Therapeutic Vaccination Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China Therapeutic advances in the management of chronic hepatitis B infection.A mechanism to explain the selection of the hepatitis e antigen-negative mutant during chronic hepatitis B virus infection Effect of viral load on T-lymphocyte failure in patients with chronic hepatitis B.Molecular characteristics and stages of chronic hepatitis B virus infection Peripheral T-lymphocyte subpopulations in different clinical stages of chronic HBV infection correlate with HBV load Hepatitis B virus DNA is more powerful than HBeAg in predicting peripheral T-lymphocyte subpopulations in chronic HBV-infected individuals with normal liver function tests Future directions in the treatment of HIV-HBV coinfection.

P2860

Q26751334-4C44A57E-A5DD-4B1F-ADCD-570CFE4B8DF6 Q26753195-2192E7C4-D039-4DDF-BDB1-DF9FA2F5D8FD Q26774875-1C5C4168-09BD-433E-A590-63C5E466B1EE Q26824158-E54E8A23-0AB9-46E2-B310-9245E48B120E Q27490236-DE7D7FF7-1E80-4A92-9D24-058FC4A8B154 Q27675395-3444D6CF-669D-4E08-9A8F-52AB6661C219 Q28073299-23C1E806-68CE-4597-A00D-F3850D606BFE Q28083160-EC91CE9C-1EC2-498C-B3CB-FF73E0FD6A84 Q28485228-CAB90439-31B8-4C03-88C6-DFBB9AD5F41A Q28818406-494E3BD3-D8EB-4B83-BBB0-99D2AA03D888 Q30196669-04AE220C-4B8D-4A7E-901A-A2970434C6B1 Q30235028-3C57F387-178E-4F43-BFDE-F9A05E8115FD Q33796676-E9D69E81-7396-4072-8A57-8228B564C9AD Q33927327-D249CD29-34D9-40D9-9411-A7ED64B19311 Q34137308-39D2FB2D-3DDE-4D79-872D-627C4E6D7ABC Q34328969-178A060B-18F3-4A4A-9736-A05FB33D2DA1 Q34362568-DB1BDEBF-2DE0-4D3E-A337-0B4D82DA2597 Q34505113-49214C72-8BA9-4AEC-AA72-B084B5263F0D Q34984576-9A3CE451-8AD2-40D5-8A64-7C624530A2A8 Q35102006-26BC38A7-6694-4636-AF54-01009884F732 Q35152364-29DD0D20-C2C7-4D89-9144-03D7B113EDCE Q35303894-CAF53AD7-9541-403A-B0A9-5B4FF29E2C92 Q35712564-7EBC8C3C-2286-484B-832C-0C5362F6D9B1 Q35786326-3525AB73-CA5F-4EE8-A901-392D029BB28A Q35857548-7B123CE6-470F-47EC-ACA9-AA247713665D Q36099102-FD15D272-3AC6-486D-9805-0B4D9EBE706B Q36101272-4A056AE6-0F6B-4FB3-AFC1-FCAB3D922073 Q36423998-0C7551D9-B81D-4F8D-BD21-D81DD7DE7D65 Q36569744-2287D9F0-7B5C-4C45-A549-3E61AC57E596 Q36614504-07F102CB-AAA8-4BB5-A0A1-D67300B9D4C4 Q36746907-D567B5B1-094B-4202-A1DB-428482989232 Q36776755-36D89187-0678-4868-B27C-144C0CF61F91 Q36971122-1D88BC76-9AF7-4372-BB02-3478B0C8BD5A Q36971785-5DE81E6B-75F4-4C1D-9B40-82D6EFE79700 Q37051594-11550C4E-DE84-460E-B2D4-158E88EB730B Q37209954-D27D4A43-3A9C-419A-9B51-5B40C8B62FB9 Q37250341-D1C2CAA5-2783-4D98-971C-FF35C40A6CDE Q37267440-69EF3AB8-446E-4AFD-9AF1-507E74987921 Q37284817-010D2589-E250-4122-8BC3-18795E982316 Q37439933-E3B63CC8-83FC-49F4-A0A8-37EADFEBF71D

P2860

Immune tolerance split between hepatitis B virus precore and core proteins.

http://www.wikidata.org/entity/Q33835018

description

2005 nî lūn-bûn

@nan

2005 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մարտին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Immune tolerance split between hepatitis B virus precore and core proteins.

@ast

Immune tolerance split between hepatitis B virus precore and core proteins.

@en

type

label

Immune tolerance split between hepatitis B virus precore and core proteins.

@ast

Immune tolerance split between hepatitis B virus precore and core proteins.

@en

prefLabel

Immune tolerance split between hepatitis B virus precore and core proteins.

@ast

Immune tolerance split between hepatitis B virus precore and core proteins.

@en

P1433

Q33835018-AEF59642-8371-4329-9705-B383E6ECD854

P1476

Q33835018-5D62EB9F-F008-476D-86C2-66608C2B9929

P2093

Q33835018-3A4B9427-321F-44D6-917C-837517CB4703

Q33835018-5A1FC253-B386-4BE7-A97C-79A20A668C6C

Q33835018-6A80516F-DC9F-492A-A5A4-F1D3769ACD84

Q33835018-75CC7162-AAF9-4BDD-A548-103B914D2F71

Q33835018-80686C2A-1861-454F-837D-CE0E27145E95

Q33835018-A08AB292-49FD-4D32-B78F-1B761F311A3C

P2860

Q33835018-0BBA50C5-40F3-4EF5-B52E-9B1753BB0A65

Q33835018-10FC1D9F-4CEA-4B10-9896-5BE33F540D57

Q33835018-1526B364-8F2C-4C8A-BA8A-8D5EAFB544DF

Q33835018-203A39A8-9FB5-4B3F-9CCB-F0D2712C77CF

Q33835018-2198F621-17A5-422A-A657-82C363942FA8

Q33835018-300D7123-D9FD-4C08-8AEB-D4018586A41E

Q33835018-32DF8683-8591-42F6-8B62-5BBA7CE0CC6A

Q33835018-35C389C7-0076-48FA-9181-B7C6DADDAB72

Q33835018-3774B679-322B-4677-8FD6-E3CA0B92D517

Q33835018-494F36D1-15C7-4054-8BAE-44A32FF6731A

P304

Q33835018-4B4A0B76-7888-476C-8FF8-98ACCAEC2B21

P31

Q33835018-3CC1FAD2-6A14-4FAC-A8E2-95CF8D432881

P356

Q33835018-BEF97B65-03A2-4EDC-B25B-3463C5FAA231

P433

Q33835018-3D070E87-B5F2-4385-9A1B-6872F5C28780

P478

Q33835018-AF5A799E-B9B5-4EAB-AA03-581F17976861

P50

Q33835018-12FED050-50AC-447B-BDC0-364AF3D0CD66

Q33835018-758D2168-66C4-44C1-A550-1834599D4598

P577

Q33835018-B91A6B5D-473C-4707-B0EE-1E47907E5431

P698

Q33835018-B01867B8-52EB-428F-8696-0EB97299479A

P932

Q33835018-4EC91AF5-2A23-40F3-B26F-5B53B809629B

P356

JVI.79.5.3016-3027.2005

P1433

Journal of Virology

P1476

Immune tolerance split between hepatitis B virus precore and core proteins.

@en

P2093

David R Milich

http://www.w3.org/2001/XMLSchema#string

Janice Hughes

http://www.w3.org/2001/XMLSchema#string

Jean-Noel Billaud

http://www.w3.org/2001/XMLSchema#string

Joyce Jones

http://www.w3.org/2001/XMLSchema#string

Margaret Chen

http://www.w3.org/2001/XMLSchema#string

Matti Sällberg

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis B virus nucleocapsid particles do not cross the hepatocyte nuclear membrane in transgenic mice

Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?

The precore gene of the woodchuck hepatitis virus genome is not essential for viral replication in the natural host

Precore stop mutant in HBeAg-positive patients with chronic hepatitis B: clinical characteristics and correlation with the course of HBeAg-to-anti-HBe seroconversion.

Autoimmunity, self-tolerance and immune homeostasis: from whole animal phenotypes to molecular pathways.

Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection.

Critical overview and outlook: pathogenesis, prevention, and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus.

Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen.

High-level hepatitis B virus replication in transgenic mice.

P304

3016-3027

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.79.5.3016-3027.2005

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P50

Francis V. Chisari

Luca G. Guidotti

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15709022

http://www.w3.org/2001/XMLSchema#string

P932

548461

http://www.w3.org/2001/XMLSchema#string